Hougen Elizabeth L's Form 4 filing
Ionis Pharmaceuticals Inc (IONS) · filed Feb 2, 2026
- Accession no.
- 0000874015-26-000098
- Filed
- Feb 2, 2026
- Trade date
- Jan 29-30, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $581.7K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Hougen Elizabeth LCIK 0001074773 | Officer (EVP, Finance & CFO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jan 29, 2026 | Common Stock | AGrant or awardAcquired | +13,562 | $0.00 | $0 | 139,869 | Direct | |
| Jan 30, 2026 | Common Stock | SSaleDisposed | −6,988 | $83.24 | −$581,681.12 | 132,881 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.